Kalaris Therapeutics, Inc. (KLRS)
NASDAQ: KLRS · Real-Time Price · USD
5.52
+0.01 (0.18%)
Apr 30, 2026, 4:00 PM EDT - Market closed
Kalaris Therapeutics Market Cap
Kalaris Therapeutics has a market cap or net worth of $126.56 million as of April 30, 2026. Its market cap has decreased by -1.64% in one year.
Market Cap
126.56M
Enterprise Value
10.03M
1-Year Change
-1.64%
Ranking
Category
Stock Price
$5.52
Market Cap Chart
Since March 19, 2025, Kalaris Therapeutics's market cap has decreased from $214.52M to $126.56M, a decrease of -41.00%. That is a compound annual growth rate of -37.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 126.33M | -19.96% |
| Dec 31, 2025 | 157.85M | -26.42% |
| Mar 19, 2025 | 214.52M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Connect Biopharma Holdings | 143.00M |
| Kazia Therapeutics | 141.92M |
| Edesa Biotech | 141.28M |
| Immunic | 136.41M |
| TuHURA Biosciences | 133.51M |
| Equillium | 131.51M |
| Innate Pharma | 131.03M |
| Alpha Cognition | 128.47M |